EZH2 and B-cell chronic lymphocytic leukemia: Further decisive support for a role of EZH2 in the apoptosis resistance exhibited by CLL cells with high EZH2 expression was provided by our pharmacological experiments in primary CLL cells, whereby treatment with EZH2 inhibitors led to reduced H3K27me3 levels and induction of apoptosis.